Company Filing History:
1 out of 273 
1 out of 31 
Years Active: 2011
Title: Michio Sata: Innovator in Crohn's Disease Research
Introduction
Michio Sata is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of medical research, particularly in the diagnosis of Crohn's disease. His innovative work has led to the development of a unique epitope peptide that plays a crucial role in identifying this condition.
Latest Patents
One of Michio Sata's notable patents is for a Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease. This patent describes an epitope peptide capable of binding specifically to an antibody characteristic of Crohn's disease, which is observed in affected patients. The invention includes a test method that allows for the convenient and rapid determination of whether a subject is affected by Crohn's disease using the peptide. The epitope peptide comprises a peptide with amino acid sequences represented by any one of SEQ ID NOS: 1 to 3 or a salt thereof. This advancement provides a valuable tool for medical professionals in diagnosing Crohn's disease.
Career Highlights
Throughout his career, Michio Sata has worked with reputable organizations, including Toagosei Company, Ltd. and Kurume University. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Some of Michio Sata's notable coworkers include Mikio Niwa and Katsuhiko Matsuo. Their collaborative efforts have furthered research in the field and enhanced the development of diagnostic tools for Crohn's disease.
Conclusion
In summary, Michio Sata is an influential inventor whose work in developing a Crohn's disease antibody epitope peptide has the potential to improve diagnostic methods for this condition. His contributions to medical research continue to impact the field positively.